DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Orvepitant is an investigational drug.
There have been 9 clinical trials for Orvepitant. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2009.
The most common disease conditions in clinical trials are Disease, Depressive Disorder, Major, and Depressive Disorder. The leading clinical trial sponsors are GlaxoSmithKline, Nerre Therapeutics Ltd., and [disabled in preview].
Recent Clinical Trials for Orvepitant
|Mass Balance Study of [14C]-Orvepitant Oral Solution in Healthy Male Subjects||Nerre Therapeutics Ltd.||Phase 1|
|A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers||Nerre Therapeutics Ltd.||Phase 1|
|A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis||Nerre Therapeutics Ltd.||Phase 2|